(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 4.04% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.25%.
Thermo Fisher Scientific's revenue in 2024 is $42,346,000,000.On average, 8 Wall Street analysts forecast TMO's revenue for 2024 to be $16,375,139,154,152, with the lowest TMO revenue forecast at $16,343,680,291,310, and the highest TMO revenue forecast at $16,408,619,537,530. On average, 8 Wall Street analysts forecast TMO's revenue for 2025 to be $17,438,748,508,344, with the lowest TMO revenue forecast at $17,290,322,603,193, and the highest TMO revenue forecast at $17,589,979,024,942.
In 2026, TMO is forecast to generate $18,722,826,603,453 in revenue, with the lowest revenue forecast at $18,598,218,121,842 and the highest revenue forecast at $18,942,094,350,311.